Senate Committee Passes Nomination Hearing for FDA Commissioner
The Senate Health, Education, Labor, and Pensions Committee held
a confirmation hearing for Marty Makary, M.D., M.P.H., for the position of Food and Drug
Administration (FDA) Commissioner.
Dr.
Makary is a surgeon and public policy researcher at Johns Hopkins University.
He has written for The Washington Post and The Wall Street Journal
and is the author of two New York Times bestselling books, Unaccountable
and The Price We Pay. Dr. Makary served in leadership positions at the
World Health Organization Patient Safety Program and was elected, in 2018, to the National Academy of Medicine.
Makary emphasized his goals for the FDA, including advancing
cures, meaningful treatments, diagnostics and rebuilding public trust. He praised
President Donald Trump and Secretary of Health and Human Services Robert F. Kennedy,
Jr., for an opportunity to bring transparency and empower people to manage their
health while committing to maintaining the FDA’s gold standard of science and
common sense. When pressed by senators to clarify his stance on vaccines, he affirmed
his support, stating that vaccines save lives and that preventable child deaths are a modern tragedy.
Dr. Makary’s nomination passed favorably, by a 14-9 vote, out of committee. The nomination
moves to the Senate floor for final approval.